Related Experiment Videos
Absence of a pharmacokinetic interaction between enalapril and frusemide
British Journal of Clinical Pharmacology
|January 1, 1987
Abstract:
Single doses of enalapril maleate 10 mg and frusemide 80 mg do not significantly affect the pharmacokinetics of each other when taken concomitantly. Their concomitant use may be associated with more adverse effects than with the individual entities.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Estradiol and weight are covariates of paracetamol clearance in young women.
Gynecologic and obstetric investigation·2014
Weight, pregnancy and oral contraceptives affect intravenous paracetamol clearance in young women.
European review for medical and pharmacological sciences·2014
Pharmacokinetics of intravenous ketorolac following caesarean delivery.
International journal of obstetric anesthesia·2012
Cefazolin plasma protein binding and its covariates in neonates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2012
Pharmacokinetics of a loading dose of intravenous paracetamol post caesarean delivery.
International journal of obstetric anesthesia·2012
Analysis of queries in an HIV drug-drug interaction checker to explore changes in prescribing patterns: A 5-year analysis.
British journal of clinical pharmacology·2026
Population pharmacokinetics of levetiracetam in term neonates with hypoxic-ischemic encephalopathy and therapeutic hypothermia: The LEVNEONAT-1 study.
British journal of clinical pharmacology·2026
Pharmacokinetic and pharmacodynamic interaction of enavogliflozin, a sodium-glucose cotransporter 2 inhibitor, with glimepiride and metformin in healthy participants.
British journal of clinical pharmacology·2026
Drug repurposing in fibrosis: From molecular networks to antifibrotic therapeutics-A narrative review.
British journal of clinical pharmacology·2026
Absorption, distribution, metabolism and excretion of londamocitinib after single-dose inhaled, intravenous and oral administration in healthy participants.
British journal of clinical pharmacology·2026
Phase 1, open-label, randomized study of the elecoglipron pharmacokinetic profile in healthy participants under fed and fasted conditions.
British journal of clinical pharmacology·2026
Monitored, unmonitored, and solitary opioid use among overdose survivors in San Francisco and Boston.
The International journal on drug policy·2026
Clinical implications of Brivaracetam Cross-Reactivity with levetiracetam immunoassay.
Epilepsy & behavior : E&B·2026
Beyond the minipill: a review of progestin-only oral contraception.
Current opinion in obstetrics & gynecology·2026
Comparison of Labeled Dosages Between Japan and the United States for Drugs Approved in Japan from 2020 to 2025.
Therapeutic innovation & regulatory science·2026
Pharmaceutical company payments to medical school deans and university hospital directors in Japan: a nationwide cross-sectional study.
International journal for quality in health care : journal of the International Society for Quality in Health Care·2026
[Clinical challenges and toxicology of nitazenes].
Ugeskrift for laeger·2026